Clinical Trials in Miami

Showing 2841-2860 of 9,821 trials

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

NCT06942572

This Phase 1/2 study will evaluate the safety, tolerability, and preliminary efficacy of subretinal SB-007 administration to determine dose selection in subjects with Stargardt's Type 1 (STGD1). This is a multicenter study which will enroll approximately 57 subjects, followed up over a 96 week period post treatment after a single administration of SB-007.

Stargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy

Splice Bio57 participantsStarted Feb 2025

Aurora, Colorado, United States • Miami, Florida, United States • Boston, Massachusetts, United States +2 more locations

COMPLETEDPhase 3< 1 mile

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

NCT02497287

The purpose of this open-label, multicenter study is to assess the long term safety and efficacy of intranasal esketamine plus an oral antidepressant in participants with treatment-resistant depression (TRD).

Treatment-resistant Depression

Janssen Research & Development, LLC802 participantsStarted Sep 2015

New Haven, Connecticut, United States • Miami, Florida, United States • Marietta, Georgia, United States +106 more locations

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

Find Trials by Condition in Miami

A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus

A Study of Seltorexant in Participants With Probable Alzheimer's Disease

A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

Linking Endotypes and Outcomes in Pediatric Acute Respiratory Distress Syndrome

Visualization of the STN and GPi for DBS

A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus

DALY II USA/ MB-CART2019.1 for DLBCL

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma

The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older

A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections

A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression

Study to Evaluate Efficacy, Safety and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder Without Psychiatric Comorbidity

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

Pulmonary Hemodynamics During Exercise - Research Network

A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL

Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA

An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants

A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus